Stem cell research benefits business
Tags: STEM cells; BUSINESS enterprises; PUBLIC finance
Related Articles
- Research & Markets: Stem Cells Research - 2011 Global Strategic Business Report. // Biomedical Market Newsletter;5/21/2011, p965
The article lists several companies included in the report analyzing the market for stem cells research in the U.S.
- Stem-Cell Support. Saskal, Rich // Bond Buyer;10/22/2004, Vol. 350 Issue 31995`, p33
Reports on the likely support of the Californians to a bond measure to fund stem cell research.
- Liberal reading of Bush edict gives US stem cell researchers more freedom. Cohen, Philip // New Scientist;8/17/2002, Vol. 175 Issue 2356, p15
Reports the interpretation of the rules governing federal funding of embryonic stem cell research in the U.S. Announcement on the use of federal funds; Availability of cell lines; Clarification of the stem line rule by the National Health Institute.
- A WIDE RANGE OF POLICIES. Johnson, Alissa // State Legislatures;Apr2005, Vol. 31 Issue 4, p26
Provides information on several stem cell policies in various U.S. states. Encouragement of embryonic stem cell research in California and New Jersey; Restriction of research on aborted fetuses or embryos; Prohibition on the use of funds for the research in Nebraska.
- Italians sue over stem cells. Abbott, Alison // Nature;7/2/2009, Vol. 460 Issue 7251, p19
The article reports on the appeal made by three Italian scientists on the decision of the Italian government in omitting human embryonic stem cells from its plan to finance stem-cell research in 2009 in Italy. According to the lawyer of the scientists Vittorio Angiolini, it violates the...
- CHEMICON SIGMS PACT WITH STEM CELL FOR MANUFACTURING. // Worldwide Biotech;Dec2005, Vol. 17 Issue 12, p1
Reports on an agreement forged by Chemicon International Inc. with Stem Cell Sciences Holdings LTD in December 2005, to develop embryonic stem cell media for the research market. Terms of the agreement; Background of the companies; Significance of the agreement to Chemicon.
- California Stem-Cell Case Winds Down. Saskal, Rich // Bond Buyer;3/3/2006, Vol. 355 Issue 32331, p1
The article reports on the case over the validity of California's plans to issue $3 billion in general obligation bonds to finance stem-cell medical research. Opponents of the medical stem-cell research argue that the voter-approved Proposition 71 violated the state constitution because it...
- Responsible Oversight of Human Stem Cell Research: The California Institute for Regenerative Medicine's Medical and Ethical Standards. Lomax, Geoffrey P.; Hall, Zach W.; Lo, Bernard // PLoS Medicine;May2007, Vol. 4 Issue 5, pe114
California voters recently approved $3 billion over 10 years for public funding of stem cell research through the California Institute for Regenerative Medicine (CIRM). Geoffrey Lomax and colleagues discuss the principles that guided the CIRM regulations.
- New Jersey Voters Defeat Stem Cell Funding Proposal. Townsend, Liz // National Right to Life News;Dec2007, Vol. 34 Issue 12, p8
The article reports that voters in New Jersey defeated the proposal of state Governor Jon Corzine on November 6, 2007 for new centers for embryonic stem cell research. The ballot measure would have provided bonds in addition to funds already earmarked by the legislature. Despite the rejection of...
